Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease reversal » increases reversal (Expand Search)
less decrease » mean decrease (Expand Search), we decrease (Expand Search), levels decreased (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
Showing 141 - 160 results of 8,324 for search '(( significant decrease reversal ) OR ( significantly ((less decrease) OR (teer decrease)) ))', query time: 0.41s Refine Results
  1. 141
    RNA-seq data on <i>inha-/-</i> vs. control (<i>bmp15+/+;inha+/+</i>).

    RNA-seq data on <i>inha-/-</i> vs. control (<i>bmp15+/+;inha+/+</i>). by Yue Zhai (3141960)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  2. 142
    Rescue of vitellogenic growth in <i>bmp15-/-</i> females by E2 treatments.

    Rescue of vitellogenic growth in <i>bmp15-/-</i> females by E2 treatments. by Yue Zhai (3141960)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  3. 143
    Interaction of <i>bmp15</i> and <i>gdf9</i> in zebrafish follicle development.

    Interaction of <i>bmp15</i> and <i>gdf9</i> in zebrafish follicle development. by Yue Zhai (3141960)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  4. 144
    Expression of 20 selected DEGs from the TGF-β signaling, endocytosis and receptor-mediated endocytosis pathways.

    Expression of 20 selected DEGs from the TGF-β signaling, endocytosis and receptor-mediated endocytosis pathways. by Yue Zhai (3141960)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  5. 145
    Testis development and spermatogenesis in <i>bmp15</i>, <i>inha</i>, and <i>inhbaa</i> mutant males.

    Testis development and spermatogenesis in <i>bmp15</i>, <i>inha</i>, and <i>inhbaa</i> mutant males. by Yue Zhai (3141960)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  6. 146
    Mutagenesis of <i>bmp15</i> and mutant characterization.

    Mutagenesis of <i>bmp15</i> and mutant characterization. by Yue Zhai (3141960)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  7. 147
    Spatiotemporal expression of <i>bmp15</i> and other genes in the follicle and during folliculogenesis.

    Spatiotemporal expression of <i>bmp15</i> and other genes in the follicle and during folliculogenesis. by Yue Zhai (3141960)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  8. 148
    RNA-seq data on <i>bmp15-/-</i> vs. control (<i>bmp15+/+;inha+/+</i>).

    RNA-seq data on <i>bmp15-/-</i> vs. control (<i>bmp15+/+;inha+/+</i>). by Yue Zhai (3141960)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  9. 149
    Effect of fadrozole on vitellogenic growth in <i>bmp15</i> and <i>inha</i> double mutant.

    Effect of fadrozole on vitellogenic growth in <i>bmp15</i> and <i>inha</i> double mutant. by Yue Zhai (3141960)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  10. 150
    Expression of selected genes at PG and PV stages in <i>bmp15</i> mutant.

    Expression of selected genes at PG and PV stages in <i>bmp15</i> mutant. by Yue Zhai (3141960)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  11. 151
    Histological analysis of the control (<i>bmp15+/-;inha+/-;inhbaa+/-</i>) and double mutants (<i>bmp15-/-;inhbaa-/-</i> and <i>inha-/-;inhbaa-/-</i>) at 120 dpf.

    Histological analysis of the control (<i>bmp15+/-;inha+/-;inhbaa+/-</i>) and double mutants (<i>bmp15-/-;inhbaa-/-</i> and <i>inha-/-;inhbaa-/-</i>) at 120 dpf. by Yue Zhai (3141960)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  12. 152
    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay

    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 153
    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay

    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 154
    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay

    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 155
    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay

    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 156
    Sensitized BLyS<sup>-/-</sup> demonstrated significantly fewer naïve and MZ B lymphocytes compared to sensitized WT and APRIL<sup>-/-</sup> rodents.

    Sensitized BLyS<sup>-/-</sup> demonstrated significantly fewer naïve and MZ B lymphocytes compared to sensitized WT and APRIL<sup>-/-</sup> rodents. by Natalie M. Bath (6316517)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 157
    HA-MAD1 tumors have increased CIN and decreased p53.

    HA-MAD1 tumors have increased CIN and decreased p53. by Sarah E. Copeland (13951506)

    Published 2024
    Save to List
    Saved in:
  18. 158
    <i>CD44</i> transcripts expression in CRC cell lines.

    <i>CD44</i> transcripts expression in CRC cell lines. by Takeshi Kaida (6532907)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  19. 159
    Clinicopathological factors and <i>CD44V</i> expression in primary right colon cancer.

    Clinicopathological factors and <i>CD44V</i> expression in primary right colon cancer. by Takeshi Kaida (6532907)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  20. 160
    Clinical and laboratory measurements of patients with ALS (N = 13; Mean±SD; ns = not significant; nd = not determined; * = evidence of subgroup responsiveness).

    Clinical and laboratory measurements of patients with ALS (N = 13; Mean±SD; ns = not significant; nd = not determined; * = evidence of subgroup responsiveness). by Ann Logan (9361)

    Published 2022
    Save to List
    Saved in:

Search Tools: